ArticleFrontiers in oncology2021

High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma.

Tianzhu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.